Class Dismissed

July 03, 2019 - FDA, Drug & Medical Device, Product Liability, Pharmaceutical & Medical Devices
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
By: Erin M. Bosman and Julie Y. Park
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely the conclusion of the Alternative Summary Reporting (ASR) Program.
... ›
June 20, 2019 - Internet of Things, Product Liability, Consumer Products, CPSC
Change Is in the Air: Buerkle Withdraws Her Nomination to Chair the CPSC
By: Erin M. Bosman and Julie Y. Park
This week, Acting Chairman Ann Marie Buerkle withdrew her nomination to serve as Chairman of the U.S. Consumer Product Safety Commission (CPSC). She will wrap up her tenure as Acting Chairman, a position she has held since February 2017, on September 30, and will
... ›
June 12, 2019 - Appellate & Supreme Court, Class Certification, Product Liability, Consumer Products, Class Action
Ninth Circuit’s En Banc Hyundai Decision: Less Strict Standard For Settlement Classes
By: Penelope A. Preovolos
On June 7, 2019, an en banc Ninth Circuit panel affirmed certification of a nationwide settlement class and held, 8-3, that class certification criteria are applied less strictly in a settlement context.[1] Hyundai II preserves the ability to certify nationwide settlement classes while maintaining
... ›
June 05, 2019 - Appellate & Supreme Court, FDA, Product Liability, Pharmaceutical & Medical Devices
Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer
By: Erin M. Bosman and Julie Y. Park
The United States Supreme Court finally clarified its 11-year-old “clear evidence” standard for pharmaceutical preemption. In its much-anticipated opinion delivered by Justice Breyer, the Court unanimously reversed the Third Circuit’s holding that questions of pharmaceutical preemption should be decided by juries. Merck Sharp &
... ›
May 17, 2019 - Announcements & Press, Product Liability
The Daily Journal Names Julie Park to its list of 2019 Top Women Lawyers in California
We’re proud to announce that the Daily Journal has named Julie Park to its list of 2019 Top Women Lawyers in California. The annual award series recognizes the successes of women lawyers in the court room and at the negotiating table, as well as
... ›
April 01, 2019 - Product Liability
Erin Bosman and Julie Park Receive “Readers’ Choice” Award
We’re proud to announce that the online platform JD Supra has named Class Dismissed editors and frequent contributors Erin M. Bosman and Julie Y. Park as recipients of the 2019 Readers’ Choice Awards. They were chosen from among the numerous writers who publish on
... ›
March 14, 2019 - Internet of Things, Product Liability, Consumer Products, CPSC
CPSC Acting Chair Buerkle’s Priorities Include IoT and Furniture Safety
By: Erin M. Bosman and Julie Y. Park
At a recent product safety conference, Ann Marie Buerkle, Acting Chair of the U.S. Consumer Product Safety Commission (CPSC), announced CPSC’s priorities for 2019. These include technology—both for consumers and within the agency—as well as window coverings and furniture tipover. Buerkle surprised the audience
... ›
October 24, 2018 - Privacy, FDA, Drug & Medical Device, Product Liability, Consumer Products
FDA Announces New Efforts to Combat Cybersecurity Threats in Medical Devices
By: Erin M. Bosman and Julie Y. Park
FDA is tackling cybersecurity threats head-on and expects industry to do the same. Earlier this month, FDA commissioner Scott Gottlieb, M.D., announced a series of developments designed to keep pace with evolving cybersecurity threats to medical devices. Industry should take note, as these developments
... ›
October 15, 2018 - Appellate & Supreme Court, Environmental Law, Product Liability, Consumer Products
BREAKING: Appellate Court Halts Trial on Coffee
By: James M. Schurz
On Friday, October 12, 2018, California’s Second Appellate District Court stayed the trial that was set to begin on Monday, October 15, 2018, in Los Angeles Superior Court, regarding whether cancer warnings are required for sales of coffee in California. The trial in Council
... ›
October 10, 2018 - Autonomous Vehicles & Robotics, Product Liability, Consumer Products
U.S. DOT Revamps Federal Guidance on Automated Vehicle Development and Rollout
By: Erin M. Bosman
Updating and building on guidance issued one year ago, the U.S. Department of Transportation published a new federal guidance document entitled Preparing for the Future of Transportation: Automated Vehicles 3.0 (“AV 3.0”). AV 3.0, released on October 4, 2018, incorporates extensive stakeholder feedback to
... ›

Topic Archives: Product Liability

Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR

By: Erin M. Bosman and Julie Y. Park

Change Is in the Air: Buerkle Withdraws Her Nomination to Chair the CPSC

By: Erin M. Bosman and Julie Y. Park

Ninth Circuit’s En Banc Hyundai Decision: Less Strict Standard For Settlement Classes

By: Penelope A. Preovolos

Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer

By: Erin M. Bosman and Julie Y. Park

The Daily Journal Names Julie Park to its list of 2019 Top Women Lawyers in California

Erin Bosman and Julie Park Receive “Readers’ Choice” Award

CPSC Acting Chair Buerkle’s Priorities Include IoT and Furniture Safety

By: Erin M. Bosman and Julie Y. Park

FDA Announces New Efforts to Combat Cybersecurity Threats in Medical Devices

By: Erin M. Bosman and Julie Y. Park

BREAKING: Appellate Court Halts Trial on Coffee

By: James M. Schurz

U.S. DOT Revamps Federal Guidance on Automated Vehicle Development and Rollout

By: Erin M. Bosman